Atlas Trials

Impact of Dapagliflozin on Intestinal Microbiota Composition and on the Metabolites Derived From the Intestinal Microbiota in Non-diabetic Chronic Renal Failure Patients

Clinical trial NCT05965440 · COMPLETED

Trial details

NCT number
NCT05965440
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Kidney Diseases
Start date
2023-11-20
Primary completion
2026-02-02
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.